Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896

Showing 1-25 of 896 citing articles:

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
Sangjune Kim, Seung‐Hwan Kwon, Tae‐In Kam, et al.
Neuron (2019) Vol. 103, Iss. 4, pp. 627-641.e7
Open Access | Times Cited: 1054
Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 781
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Lena F. Burbulla, Pingping Song, Joseph R. Mazzulli, et al.
Science (2017) Vol. 357, Iss. 6357, pp. 1255-1261
Open Access | Times Cited: 722
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
José Á. Obeso, María Stamelou, Christopher G. Goetz, et al.
Movement Disorders (2017) Vol. 32, Iss. 9, pp. 1264-1310
Open Access | Times Cited: 716
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Bruno Lima Giacobbo, Janine Doorduin, Hans Klein, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 5, pp. 3295-3312
Open Access | Times Cited: 598
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 557
Protein transmission in neurodegenerative disease
Chao Peng, John Q. Trojanowski, Virginia M.‐Y. Lee
Nature Reviews Neurology (2020) Vol. 16, Iss. 4, pp. 199-212
Open Access | Times Cited: 472
Circuit Mechanisms of Parkinson’s Disease
Matthew McGregor, Alexandra Nelson
Neuron (2019) Vol. 101, Iss. 6, pp. 1042-1056
Open Access | Times Cited: 442
Disruption of mitochondrial complex I induces progressive parkinsonism
Patricia González‐Rodríguez, Enrico Zampese, Kristen A. Stout, et al.
Nature (2021) Vol. 599, Iss. 7886, pp. 650-656
Open Access | Times Cited: 388
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 349
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 334
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang, Alberto J. Espay
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 660-677
Open Access | Times Cited: 319
Dementia with Lewy bodies: an update and outlook
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 296
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease
Julien Bryois, Nathan Skene, Thomas Hansen, et al.
Nature Genetics (2020) Vol. 52, Iss. 5, pp. 482-493
Open Access | Times Cited: 291
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 272
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 268
Microglia and astrocyte dysfunction in parkinson's disease
Tae‐In Kam, Jared T. Hinkle, Ted M. Dawson, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105028-105028
Open Access | Times Cited: 268
Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Ahmad Elkouzi, Vinata Vedam‐Mai, Robert S. Eisinger, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 4, pp. 204-223
Open Access | Times Cited: 252
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin, Ronald Melki
Journal of Neuroscience (2017) Vol. 37, Iss. 41, pp. 9808-9818
Open Access | Times Cited: 245
α-Synuclein strains target distinct brain regions and cell types
Angus Lau, Raphaella W. L. So, Heather H. C. Lau, et al.
Nature Neuroscience (2019) Vol. 23, Iss. 1, pp. 21-31
Open Access | Times Cited: 244
Network connectivity determines cortical thinning in early Parkinson’s disease progression
Yvonne Yau, Yashar Zeighami, Travis E. Baker, et al.
Nature Communications (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 241
Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis
Michael X. Henderson, Eli J. Cornblath, Adam S. Darwich, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 8, pp. 1248-1257
Open Access | Times Cited: 241
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 225
Page 1 - Next Page

Scroll to top